 Wells Fargo analyst Colin Langan upgraded Cerence Inc NASDAQ:CRNC from Equal-Weight to Overweight and an 85 price target, down from 91, implying a 15 upside. Langan noted Cerence is down about 50 from its high and 34 since reporting FY21 results and guiding below consensus for FY22. 